# Links Between Inflammation and Cardiometabolic Diseases

> **NCT01934660** · — · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 150 (actual)

## Conditions studied

- Diabetes Mellitus
- Cardiovascular Disease
- Healthy Volunteer
- Inflammation

## Interventions

- **DRUG:** 13N-amonia
- **DRUG:** Fludeoxyglucose F18

## Key facts

- **NCT ID:** NCT01934660
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12-02
- **Primary completion:** 2022-08-03
- **Final completion:** —
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01934660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01934660, "Links Between Inflammation and Cardiometabolic Diseases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01934660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*